You Searched For: N-Methylbenzamide

Supplier: Ambeed

Description: Enzalutamide 98%

Supplier: Ambeed

Description: S116836 95%

New Product

Catalog Number: (101880-374)

Supplier: Matrix Scientific

Description: Matrix Scientific Part Number: 047508-1G , MDL Number: MFCD07367975

Catalog Number: (101972-856)

Supplier: MORAVEK BIOCHEMICALS MS

Description: Midostaurin

Catalog Number: (101879-196)

Supplier: Matrix Scientific

Description: Matrix Scientific Part Number: 047266-1G , MDL Number: MFCD08689758

Supplier: Thermo Scientific Chemicals

Description: Inhibits a variety of serine/threonine and tyrosine kinases including PKC

SDS Certificates

Supplier: TCI America

Description: CAS Number: 134-62-3
MDL Number: MFCD00009046
Molecular Formula: C12H17NO
Molecular Weight: 191.27
Purity/Analysis Method: >98.0% (GC)
Form: Clear Liquid
Boiling point (°C): 160
Flash Point (°C): 140
Specific Gravity (20/20): 1.00

SDS Certificates

Supplier: Ambeed

Description: 4-Methylbenzamidoxime 97%

New Product

Catalog Number: (80017-392)

Supplier: MilliporeSigma

Description: CGP 41 251, N-Benzoylstaurosporine

SDS Certificates

Catalog Number: (76003-034)

Supplier: Enzo Life Sciences

Description: Cell-permeable, potent, selective, and reversible MMP-9 inhibitor.

Catalog Number: (102991-312)

Supplier: Adipogen

Description: AMG-Tie2-1 is a highly potent, non-selective inhibitor of Tie-2 (IC(50) <lt/>1nM).

Supplier: Enzo Life Sciences

Description: Inhibitor of a variety of serine/threonine and tyrosine kinases, like protein kinase C (PKC), cyclic AMP-dependent protein kinase (PKA), S6 kinase, Akt (protein kinase B; PKB), epidermal growth factor receptor (EGFR) tyrosine kinase activity and others including KDR, VEGFR, PDGFR, c-kit and other receptor tyrosine kinases. Potently inhibits FLT-3 kinase including mutant forms found in acute myeloid leukemia in vitro and in vivo. Apoptosis inducer. Showed broad antiproliferative activity against various tumor cell lines. Selectively inhibits T lymphocyte production of TNF-α. Upregulates endothelial nitric oxide synthase (eNOS; NOS III). Abrogates tumor angiogenesis in vivo.

Supplier: Adipogen

Description: The lymphocyte-specific kinase (Lck) is a cytoplasmic tyrosine kinase of the Src family expressed in T cells and natural killer (NK) cells. Genetic evidence in both mice and humans demonstrates that Lck kinase activity is critical for signaling mediated by the T cell receptor (TCR), which leads to normal T cell development and activation. Selective inhibition of Lck is expected to offer a new therapy for the treatment of T-cell-mediated autoimmune and inflammatory disease. AMG-47 is one of two optimized chemical compounds that has been shown to be extremely effective in vivo and in vitro in inhibiting Lck as well as a number of other receptor tyrosine kinases. In an anti-CD3/ IL-2 mouse model system AMG-47 has been shown to be effective in inhibiting the Lck mediated anti-inflammatory activity (ED50 11 mg/kg; 630nM) in vivo. In multiple other in vitro assays, AMG-47 exhibits subnanomolar inhibition against Lck, and low (<lt/>10nM) inhibition against other hard to inhibit kinases such as KDR and SRC and MAPK alpha (p38alpha). Moreover at slightly higher doses but well under 10µM, AMG-47 effectively inhibits the JNK family of kinases including TYK2 at ~ 1.2µM.

Catalog Number: (77925-275)

Supplier: AOBChem USA

Description: 4-BROMO-2-METHYLBENZAMIDE 1G

New Product

Catalog Number: (77896-717)

Supplier: AOBChem USA

Description: 3-BROMO-5METHOXY-N-METHYLBENZAMIDE 500MG

New Product

Catalog Number: (77925-574)

Supplier: AOBChem USA

Description: 246-TRICHLORO-N-METHYLBENZAMIDE 1G

New Product